Quantinno Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
258,125
-12,964
-5% -$579K 0.01% 941
2026
Q1
$13.1M Buy
271,089
+53,849
+25% +$2.51M 0.02% 762
2025
Q4
$10.5M Buy
217,240
+47,372
+28% +$2.35M 0.02% 759
2025
Q3
$8.02M Buy
169,868
+40,405
+31% +$1.95M 0.02% 751
2025
Q2
$6.25M Sell
129,463
-68,393
-35% -$3.49M 0.03% 716
2025
Q1
$11M Buy
197,856
+30,536
+18% +$1.65M 0.07% 339
2024
Q4
$8.07M Buy
167,320
+68,444
+69% +$3.48M 0.08% 276
2024
Q3
$5.7M Buy
98,876
+13,499
+16% +$729K 0.07% 310
2024
Q2
$4.14M Sell
85,377
-1,422
-2% -$68.6K 0.07% 305
2024
Q1
$4.22M Buy
86,799
+23,605
+37% +$1.15M 0.09% 242
2023
Q4
$3.14M Buy
63,194
+31,382
+99% +$1.53M 0.11% 225
2023
Q3
$1.71M Buy
31,812
+5,948
+23% +$317K 0.08% 346
2023
Q2
$1.39M Buy
25,864
+3,314
+15% +$178K 0.08% 322
2023
Q1
$1.23M Buy
22,550
+3,822
+20% +$186K 0.08% 319
2022
Q4
$907K Buy
+18,728
New +$822K 0.07% 375

Other funds holding SNY

Quantinno Capital Management's SNY Position: Q2 2026 in Review

Quantinno Capital Management reduced its Sanofi (SNY) stake by 4.8% in Q2 2026, selling an estimated $579K and leaving 258,125 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #941.

Quantinno Capital Management first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.1M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Quantinno Capital Management held 258,125 shares of Sanofi worth $11M as of Q2 2026.
  • Quantinno Capital Management sold 12,964 Sanofi shares in Q2 2026, an estimated $579K.
  • Sanofi made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #941 holding.
  • Quantinno Capital Management first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • Quantinno Capital Management's Sanofi position peaked at $13.1M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.